It seems that Pfizer continues to remain in the news amidst the latest scandal that involves the firm and the novel coronavirus. Check out the latest reports below.
Pfizer covid vaccine news is out
It’s been just revealed that the phase 3 trial of Pfizer’s maternal RSV vaccine has found the shot lowered the rate of severe RSV in newborns by 81.8%, the company announced.
It seems that the strong result spurred the pharma giant to pause the trial and prepare to file for FDA approval.
“The news comes as the US is facing a brutal early wave of RSV infections in children, a surge that is swamping pediatric hospital units,” according to official reports.
Official data notes that the respiratory syncytial virus (RSV) infects the lungs and respiratory tract, and it is so common that nearly all children have been infected at least once by the time they hit two.
“While generally mild, the virus can be fatal to infants, the elderly, and people with other chronic health conditions, and it kills about 100,000 children globally per year — with more than half less than 6 months old.”
Pfizer in the news
It’s been just reported that he has “categorically” ruled out that the pharma giant’s chief executive agreed on the European COVID-19 contract via mobile phone text messages.
According to fresh reports, the executive was involved in negotiating a covid vaccine bulk supply agreement with the European Commission.
“The European Commission signed a third contract with BioNTech SE and Pfizer for an additional 1.8 billion doses of its COVID-19 vaccine,” Benzinga’s official website notes.
According to the same reports, a new agreement will initially supply 900 million doses of the vaccine with an option to request up to an additional 900 million doses.
As per the same online publication, some interesting quotes have just been released.
“As to whether a contract negotiation such as this contract which you referred to, 1.8 billion doses, was negotiated through an SMS, I can categorically tell you that would not be the case.” Check out our previous article in order to learn more news about this.